Latest Market News

The FDA’s recent ruling classifying traditionally prepared kava beverages as food under U.S. law clears a major regulatory hurdle for The Calmer Co, accelerating its growth on Amazon and strengthening its U.S. expansion strategy.

Lifestyle Communities has restructured its debt with $425 million in new long-term facilities, simplifying its financing and resetting key covenants to support growth amid Victoria’s property market recovery.

Electro Optic Systems (EOS) has landed a US$22 million deal to supply Remote Weapon Systems for a major U.S. Army combat vehicle, marking a significant milestone in its U.S. market expansion. This contract boosts EOS’s contract backlog to over A$400 million, setting the stage for robust revenue growth in the coming years.

Scentre Group has sold a 19.9% stake in Westfield Sydney to Australian Retirement Trust for $864 million, reinforcing its strategy of capital recycling through joint ventures.

US1 Critical Minerals has obtained a Federal Court undertaking preventing the transfer or encumbrance of disputed Rare Earth tenements in California, with a trial scheduled for April 2026.

InhaleRx Limited has successfully closed its entitlement offer and placement, raising $857,730 to support the clinical development of inhaled treatments targeting cancer pain and mental health conditions.

Pure Resources has completed a $1.7 million placement to fund its Garnet Hills Garnet and Graphite Project, with options to be issued pending shareholder approval.

Antony Sage, founding director of Cyclone Metals, has lodged an application with the Takeovers Panel alleging coordinated shareholder actions to alter the board without proper disclosure. The dispute intensifies as Cyclone schedules a new meeting to consider further director removals.

DevEx Resources has successfully raised nearly $7 million through an oversubscribed Share Purchase Plan, significantly exceeding its initial $3 million target to fund expanded uranium exploration in Australia’s Northern Territory.

Next Science Limited has applied for voluntary delisting from the ASX following the sale of nearly all its assets to OSARTIS GmbH. The company proposes a capital return to shareholders and intends to commence winding up after delisting.

Next Science has obtained a crucial ASX waiver allowing it to return surplus capital to shareholders following its $50 million asset sale, despite expected share price declines below 20 cents.

Perseus Mining has expanded and refinanced its corporate debt facility to US$400 million, significantly enhancing its liquidity position to over US$1.2 billion. This move positions the gold miner strongly for future growth and shareholder returns.